News

Nick doubles down on being the villain when he’s back in New Bethlehem, and tells Rita that he no longer thinks he’s able to ...
The debate continues over the potential of measurable residual disease to transform research and clinical care in hematology.
Gilead Sciences Inc. closed 8.32% below its 52-week high of $119.96, which the company reached on March 10th.
COLUMBIA, Miss. (WDAM) - There will be a scheduled water outage on Monday morning, June 16, in parts of Marion County. The outage will begin around 8 or 9 a.m. for roughly 100 customers around: ...
Bowling Green police were dispatched to the 1000 block of Fairview Avenue on Tuesday for a report of people refusing to leave ...
COLUMBUS, Ohio (WSYX) — The ODNR Division of Wildlife said Friday that they are aware of a black bear sighting on Morrow ...
Let’s just say you wake up one morning in The Handmaid’s Tale universe, stuck inside the color-coded hellscape that is Gilead ...
During the first quarter, the Global Women’s Leadership portfolio lagged global developed market equities overall in the ...
Gilead Sciences (GILD) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review ...
Now that The Handmaid’s Tale has revealed its ending, a new tale is coming into focus: sequel series The Testaments.
Decreasing CD4 and lymphocyte counts in some participants receiving an oral combination therapy led to holds in the study.
Gilead’s HIV treatment trials involving an investigational integrase strand inhibitor (GS-1720) and an investigational capsid inhibitor (GS-4182) have been put on clinical hold by the Food and Drug ...